BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9207303)

  • 1. Correlating clinical outcome with molecular events in colorectal cancer.
    Pasricha P
    Gastroenterology; 1997 Jul; 113(1):360-1. PubMed ID: 9207303
    [No Abstract]   [Full Text] [Related]  

  • 2. DCC expression and prognosis in colorectal cancer.
    Banerjee AK
    Lancet; 1997 Apr; 349(9057):968. PubMed ID: 9100619
    [No Abstract]   [Full Text] [Related]  

  • 3. The DCC gene and colorectal cancer: the story is more complex.
    Beggs AD; Abulafi M; Hodgson SV
    Colorectal Dis; 2008 Jul; 10(6):630. PubMed ID: 18266884
    [No Abstract]   [Full Text] [Related]  

  • 4. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.
    Wettergren Y; Odin E; Nilsson S; Willen R; Carlsson G; Gustavsson B
    Cancer Detect Prev; 2005; 29(4):348-55. PubMed ID: 16122883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor genes.
    Anand A
    Hosp Pract (Off Ed); 1993 Jan; 28(1):21. PubMed ID: 8419413
    [No Abstract]   [Full Text] [Related]  

  • 7. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease.
    Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrequent inactivation of DCC gene in replication error-positive colorectal cancers.
    Yamamoto H; Itoh F; Kusano M; Yoshida Y; Hinoda Y; Imai K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):204-9. PubMed ID: 9514909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
    Kubo H; Miki C; Kusunoki M
    Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DCC changes and prognosis in colorectal carcinoma].
    Fiocca R
    Pathologica; 1998 Feb; 90(1):79-80. PubMed ID: 9628983
    [No Abstract]   [Full Text] [Related]  

  • 11. Colorectal cancer prognosis: is it all mutation, mutation, mutation?
    Hassan AB; Paraskeva C
    Gut; 2005 Sep; 54(9):1209-11. PubMed ID: 16099785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic factors and colorectal cancer: a new approach to clinical experimentation].
    Midiri G; Tesoriere A; Giarnieri E; Consorti F; Covotta A; Lorenzotti A; Urbano V; Luzzatto L; Bertolotti A; Vecchione A
    G Chir; 1999; 20(8-9):373-7. PubMed ID: 10444928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colorectal cancers and molecular biology].
    Grandjouan S
    Pathol Biol (Paris); 1992 Nov; 39(9):904-5. PubMed ID: 1311444
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular staging for survival prediction of colorectal cancer patients.
    Eschrich S; Yang I; Bloom G; Kwong KY; Boulware D; Cantor A; Coppola D; Kruhøffer M; Aaltonen L; Orntoft TF; Quackenbush J; Yeatman TJ
    J Clin Oncol; 2005 May; 23(15):3526-35. PubMed ID: 15908663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age.
    Liang JT; Huang KC; Cheng AL; Jeng YM; Wu MS; Wang SM
    Br J Surg; 2003 Feb; 90(2):205-14. PubMed ID: 12555297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple method for the routine detection of somatic quantitative genetic alterations in colorectal cancer.
    Killian A; Di Fiore F; Le Pessot F; Blanchard F; Lamy A; Raux G; Flaman JM; Paillot B; Michel P; Sabourin JC; Tuech JJ; Michot F; Kerckaert JP; Sesboüé R; Frebourg T
    Gastroenterology; 2007 Feb; 132(2):645-53. PubMed ID: 17258723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular markers in prognosis of colorectal cancer and prediction of response to treatment.
    Pasche B; Mulcahy M; Benson AB
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):331-45. PubMed ID: 11969242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
    Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
    Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
    Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
    Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DCC and colorectal carcinogenesis].
    Caca K; Zoller WG
    Z Gastroenterol; 1997 Sep; 35(9):895-7. PubMed ID: 9432822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.